Skip to main content
OpenTrials

Clinical trial condition

Non-alcoholic Fatty Liver Disease

Explore clinical trials studying Non-alcoholic Fatty Liver Disease. Study availability and eligibility vary by location and protocol.

1,137 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Non-alcoholic Fatty Liver Disease trial results

Recruiting

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

NCT07221188

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • GSK Investigational Site Arcadia, California, United States
  • GSK Investigational Site Covina, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 53 locations
View Trial Details
Recruiting

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07288138

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • Arizona Liver Health - Peoria Peoria, Arizona, United States
  • Adobe Clinical Research, LLC Tucson, Arizona, United States
  • Arizona Liver Health - Tucson Tucson, Arizona, United States
View all 62 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

NCT06419374

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +7 more
Locations
  • 89bio Clinical Study Site Birmingham, Alabama, United States
  • 89bio Clinical Study Site Homewood, Alabama, United States
  • 89bio Clinical Study Site Chandler, Arizona, United States
  • 89bio Clinical Study Site Flagstaff, Arizona, United States
View all 317 locations
View Trial Details
Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT06318169

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +7 more
Locations
  • 89bio Clinical Study Site Birmingham, Alabama, United States
  • 89bio Clinical Study Site Chandler, Arizona, United States
  • 89bio Clinical Study Site Flagstaff, Arizona, United States
  • 89bio Clinical Study Site Glendale, Arizona, United States
View all 361 locations
View Trial Details
Recruiting

NAC- NAFLD And Cushing

NCT05881005

Conditions
Adrenal Gland Diseases, Adrenocortical Hyperfunction, Cushing Syndrome, +6 more
Locations
  • University Hospital, Angers Angers, France
  • University Hospital, Bordeaux Bordeaux, France
  • University Hospital, Brest Brest, France
  • University Hospital, Grenoble Grenoble, France
View Trial Details
Recruiting

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

NCT05519475

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • The Institute for Liver Health II LLC DBA Arizona Clinical Trials - Flagstaff Flagstaff, Arizona, United States
  • The Institute for Liver Health II LLC DBA Arizona Liver Health - Peoria Peoria, Arizona, United States
  • Adobe Clinical Research Tucson, Arizona, United States
View all 71 locations
View Trial Details

Related conditions